Professional Documents
Culture Documents
127 4W2
Coping with the 5 stages of Parkinson’s Disease. Late Adulthood and living with
This research paper is dedicated to Robert O. Lofland, my father, who worked for
Pennsylvania Railroad, Penn Central Railroad, and Conrail, 8th District. First as a track
laborer and advanced to bridge operator at the C&D canal. The 8th was recognized by
CONRAIL having the best safety records in the mid-Atlantic region, with no accidents in 34
years. Known as Pop or Dad to many, though I was his only son. He was first diagnosed with
Parkinson’s in 1993, his wife- my mother stayed by his side until passing away from
complications of Parkinson’s. He went to be with our Lord and Savior on Dec. 23, 1999 due
Also, my friend Dr. Kelly Lyons PhD who I had the honor to know while she was at
Research Assistant Professor. She served as a Research Assistant Professor in the Department of
Neurology at the University of Miami from 1995-2003. Since that time, Dr. Lyons, alumni of the
University of Kansas, and native of the state, re-joined the faculty in the Department of
Neurology at the University of Kansas Medical Center. Today Dr. Lyons is a Research Professor
Late Adulthood and living with movement disorders PD Tremors. Essential Tremors and
Dykinesia.
Though some of this Research paper will come from my own personal experiences while I was a
personal caregiver for my father. I will be adding vital information from the medical community
and its research teams, who have worked tirelessly to find ways to diagnose Parkinson’s Disease
earlier, and finding a cure for Parkinson’s. Many medical professionals around the world have
been responsible for ground breaking- new medical technology that is helping patients cope with
a variety of symptoms associated with Parkinson’s Disease as with providing a higher quality of
life to those in late adulthood battling diseases that cause movement disorders including
Alzheimer’s Disease as well as other movement disorders that are not discriminatory to age sex
religion or creed. Multiple Sclerosis, Early Onset Parkinson’s Disease. dyskinesia as well as
depression and anxiety that impact a wide number of people who may or may not have a
movement disorder. The most difficult part of this report will be keeping it brief.
Bibliography
Quentin Shires has taught psychology and other social science classes at the university level and
is considered a doctoral colleague at Capella University
Sietske N. Heyn is a medical writer with a PhD in neuroscience. Dr. Heyn's education includes a
BS with honors from the University of Oregon, and a doctoral degree in neuroscience from
the University of California at Davis.
Dr. J William Langston over 30 years of experience in the Parkinson’s field, known for
both clinical and basic research in Parkinson’s disease, as well as in day-to-day patient
care. Dr Langston has published about 400 scientific papers regarding disease -modifying
therapies for disease, ways to treat the side-effects of chronic levodopa therapy (in
particular levodopa-induced dyskinesias or Parkinson’s Disease Dyskinesia), the genetics
of Parkinson’s disease and related disorders and the epidemiology of the disease. He
originally gained national and international discovering the cause of parkinsonism in a
group of young heroin addicts in Northern California who after using a “synthetic heroin”
developed severe parkinsonism.
Dr. Kelly E. Lyons re-joined the faculty in the Department of Neurology at the University of
Kansas Medical Center in 2003 as a Research Associate Professor and Director of Research for
the Parkinson's Disease and Movement Disorder Center. Her primary areas of research are
Parkinson’s disease and essential tremor. She has over 200 articles and presentations in these
areas, and is co-editor of the Handbook of Parkinson’s disease, 3d, 4th, and 5th Ed. Therapy of
Parkinson’s Disease 3d Ed. And Handbook of Essential Tremor and other Tremor Disorders Dr.
Lyons is the President of the International Essential Tremor Foundation; Co-Editor in Chief of
the International Journal of Neuroscience, and Editor and Chair of the Movement Disorder
Journal CME committee.
Parkinson's disease (PD) is the second most common age-related neurodegenerative disorder.
Due to the progressive loss of substantia nigra pars compacta dopamine neurons the person with
Parkinson’s decreases in producing the neurotransmitter dopamine Dopamine levels affect bodily
functions such as movement, memory, sleep and mood. Dopamine is known as a part of the
reward center that is also associated with a variety of addictions. It is produced in the ventral
tegmental area (VTA) substantia Nigra pars compacta and the hypothalamus of the brain.
(Shires)
(image 1) his image is in the public domain due to being materials that originally came from the
Parkinson’s Disease is a movement disorder that can affect not only the physical aspects of
a person's life, that includes speaking, eating writing. As well as walking. It also has a role in the
mental health as well of a person battling the disease. There is no specific cause for Parkinson’s,
and currently there is also no cure for the disease. Most know this disease by the famous people
who have been diagnosed with the disease. Former Attorney General Reno. Pope John Paul.
Michael J. Fox. Evangelist Rev. Billy Graham and Actor Allen Alda
movement in their hands, arms, upper torso as well as their lower extremities, typically
called dyskinesia, that can be misdiagnosed for “tremors” and “rigidity”, also symptoms
externally and internally that increases the risk of falls often times causing orthopedic
injuries to the patient. Dyskinesia also affects the respiratory muscles and often times
goes unrecognized until the patient has reached the latter part of stage of 2 or stage 3 of
the five stages of Parkinson’s.. those in late adulthood are typically who are diagnosed
with PD (around 60 years of age and older). However, adults, as young as 18 years of age
o Tremor
o Stiffness
o Slowness
o Impaired balance
o Anxiety
o Depression
o Dementia
Though there are 5 stages and several symptoms that can be discussed. This paper give an
insight to Parkinson’s Disease Dyskinesia and parkinsonian tremor, that has a risk
of being misdiagnosed particularly when the patient’s medical history is the the
only primary source for making the diagnoses. It is critical to make the correct
diagnosis of either symptom due to how profoundly different the treatment for
patient shows signs of dyskinesias that are affecting their quality of life, one
option would be to reduce the levodopa dosage. Levodopa is used to increase the
dopamine levels in the brain and body. Yet too much levodopa in the body will
tremors, one form of treatment would be to, increase dopaminergic therapy using
levodopa or dopamine agonist such ropinirole or pramipexole. (Langston) another
treatment to reduce both Essential Tremors associated with MS and Parkinsonian tremors
What is Dopamine?
Dopamine is a neurotransmitter created in three areas of the brain. The hypothalamus, the
Ventral tegamental area (VTA) and substantia nigra pars compacta responsible for
sending messages between the brain and different nerve cells of the body. Dopamine has
been identified as the body's reward activator, controlling the pleasure center of our brain
with low levels of dopamine are more prone to addictive behaviors, and are more likely
to use and abuse drugs consume too much food and have sexual addictions.
Parkinson’s has both motor and non-motor symptoms Most know about the motor
symptoms due to the symptoms being visible in the daily life of the patient. However
there are non-motor symptoms that are not as noticeable to others outside the patients
home. Some non-motor symptoms include hallucinations- seeing or hearing things not
there. blurry or double vision and uncontrollable sweating.(Lyons, 2013) Most patients
go undiagnosed with the disease until the motor symptoms have begun to impact their
life. Many times, not until after an individual has a Transient Ischemic Attack (TIA or
“mini stroke”) will the patient be diagnosed with Parkinson’s. Or, by that time the motor
symptoms are far advanced where they have lost motor functions that include walking
with a gait, or tripping caused by dragging their feet, shaking in their hand(s) or their
arms is not moving normally while they are walking. These and other similar symptoms
are typically associated with the latter part of stage 2 or the beginning of stage 3 of
Parkinson’s disease, where the brain is no longer producing adequate amounts of the
patient as well as being overlooked by clinicians, often times by those who have not been
around patients with Parkinson’s and are familiar with the non-movement symptoms
associated with PD. The non-motor symptoms are often occurring long before the motor
of PD patients didn’t declare non-motor symptoms such as apathy, pain, sexual difficulty,
bowel incontinence or sleep disorder, due to embarrassment or just being unaware these
Silent strokes often are unnoticeable. However, research suggests silent strokes have
lasting effects.
Dr. Pinteaux and a team of researchers induced a silent stroke like state (mild stroke) in
the striatum area of the brain of laboratory mice. Not surprisingly, he and his team
dopaminergic neurons start to die in the brain and therefore why people get Parkinson's
disease. There have been suggestions that oxidative stress and aging are responsible.
What we wanted to do in our study was to look at what happens in the brain away from
the immediate area where a silent stroke has occurred and whether that could lead to
Recently ‘movement symptoms associated with Parkinson’s Disease had been a key
subject in providing Parkinson Patients who are stage four or higher, suffering with
Parkinsonian Tremors a less invasive procedure than Deep Brain Stimulation that also
Though relatively safe, like any major surgery has its risks that include infection of the
stroke (Mayo Clinic) as Deep Brain Stimulation does, where a small device (pacemaker) is
placed inside the patient’s chest and sends electrical pulses to the brain. The pulses block
nerve signals that cause tremors and other movement disorders. (WebMed). DBS has also
been used for treating patients with Obsessive Compulsive Disorders as well as depression.
technology has been used to eliminate the symptoms of Dyskinesia This procedure is less
invasive and shows positive signs for not damaging other areas of the brain (Schlesinger, et al
2017) .
Currently there is no cure for Parkinson’s Disease. For some patients with PD MRgFUS
provides an alternative to treat the underlying disease pathology with potential of preventing
brain – and therefore has reduced risk for infection and blood clots.
• Compared to deep brain stimulation, focused ultrasound is a single procedure, and does
adjust simulator settings. It also does not involve the collateral damage to healthy tissue
Heyn SN, Davis CP and Stoppler MC “Parkinson’s Disease Symptoms Cures, Stages,
Treatment, and life expectancy” MedicineNet
https://www.medicinenet.com/parkinsons_disease/article.htm#parkinsons_definiti
on_and_disease_facts
TED TV, (2013) with Dr. Kelly Lyons “Redefining Parkinson's Disease
https://www.youtube.com/watch?v=gJidzMJERmw